Trial protocol OPPTIMUM– Does progesterone prophylaxis for the prevention of preterm labour improve outcome?
Preterm birth is a global problem, with a prevalence of 8 to 12% depending on location. Several large trials and systematic reviews have shown progestogens to be effective in preventing or delaying preterm birth in selected high risk women with a singleton pregnancy (including those with a short cervix or previous preterm birth). Although an improvement in short term neonatal outcomes has been shown in some trials these have not consistently been confirmed in meta-analyses. Additionally data on longer term outcomes is limited to a single trial where no difference in outcomes was demonstrated at four years of age of the child, despite those in the “progesterone” group having a lower incidence of preterm birth.
The OPPTIMUM study is a double blind randomized placebo controlled trial to determine whether progesterone prophylaxis to prevent preterm birth has long term neonatal or infant benefit. Specifically it will study whether, in women with singleton pregnancy and at high risk of preterm labour, prophylactic vaginal natural progesterone, 200 mg daily from 22 – 34 weeks gestation, compared to placebo, improves obstetric outcome by lengthening pregnancy thus reducing the incidence of preterm delivery (before 34 weeks), improves neonatal outcome by reducing a composite of death and major morbidity, and leads to improved childhood cognitive and neurosensory outcomes at two years of age. Recruitment began in 2009 and is scheduled to close in Spring 2013. As of May 2012, over 800 women had been randomized in 60 sites.
OPPTIMUM will provide further evidence on the effectiveness of vaginal progesterone for prevention of preterm birth and improvement of neonatal outcomes in selected groups of women with singleton pregnancy at high risk of preterm birth. Additionally it will determine whether any reduction in the incidence of preterm birth is accompanied by improved childhood outcome.
- March of Dimes White paper on preterm birth: the global and regional toll. March of Dimes foundation, White Plains, New York
- Norman, JE, Morris, C, Chalmers, J (2009) The effect of changing patterns of obstetric care in Scotland (1980–2004) on rates of preterm birth and its neonatal consequences: perinatal database study. PLoS Med 6: pp. e1000153 CrossRef
- Goldenberg, RL, Culhane, JF, Iams, JD, Romero, R (2008) Epidemiology and causes of preterm birth. Lancet 371: pp. 75-84 CrossRef
- Arbyn, M, Kyrgiou, M, Simoens, C, Raifu, AO, Koliopoulos, G, Martin-Hirsch, P, Prendiville, W, Paraskevaidis, E (2008) Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis. BMJ (Clinical Res Ed) 337: pp. a1284 CrossRef
- da Fonseca, EB, Bittar, RE, Carvalho, MH, Zugaib, M (2003) Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J ObstetGynecol 188: pp. 419-424 CrossRef
- Fonseca, EB, Celik, E, Parra, M, Singh, M, Nicolaides, KH, Thornton, S, Alfirevic, Z, Smith, G, Radhakrishnan, P, Khoury, O (2007) Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med 357: pp. 462-469 CrossRef
- Meis, PJ, Klebanoff, M, Thom, E, Dombrowski, MP, Sibai, B, Moawad, AH, Spong, CY, Hauth, JC, Miodovnik, M, Varner, MW (2003) Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 348: pp. 2379-2385 CrossRef
- Hassan, SS, Romero, R, Vidyadhari, D, Fusey, S, Baxter, J, Khandelwal, M, Vijayaraghavan, J, Trivedi, Y, Soma-Pillay, P, Sambarey, P (2011) Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 38: pp. 18-31 CrossRef
- Dodd, JM, Flenady, V, Cincotta, R, Crowther, CA (2006) Prenatal administration of progesterone for preventing preterm birth. Cochrane Database Syst Rev 1: pp. CD004947
- Dodd, JM, Flenady, VJ, Cincotta, R, Crowther, CA (2008) Progesterone for the prevention of preterm birth: a systematic review. Obstet Gynecol 112: pp. 127-134 CrossRef
- Romero, R, Nicolaides, K, Conde-Agudelo, A, Tabor, A, O'Brien, JM, Cetingoz, E, Da Fonseca, E, Creasy, GW, Klein, K, Rode, L (2012) Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data. Am J Obstet Gynecol 206: pp. 124 e121-119 CrossRef
- Northen, AT, Norman, GS, Anderson, K, Moseley, L, Divito, M, Cotroneo, M, Swain, M, Bousleiman, S, Johnson, F, Dorman, K (2007) Follow-up of children exposed in utero to 17 alpha-hydroxyprogesteronecaproate compared with placebo. ObstetGynecol 110: pp. 865-872
- Progesterone and preterm birth prevention: translating clinical trials data into clinical practice Am J Obstet Gynecol 2012,206(5):376–386.
- Junpeng, M, Huang, S, Qin, S (2011) Progesterone for acute traumatic brain injury. Cochrane Database Syst Rev 1: pp. CD008409
- Kenyon, SL, Taylor, DJ, Tarnow-Mordi, W (2001) Broad-spectrum antibiotics for spontaneous preterm labour: the ORACLE II randomised trial. ORACLE Collaborative Group. Lancet 357: pp. 989-994 CrossRef
- Kenyon, S, Pike, K, Jones, DR, Brocklehurst, P, Marlow, N, Salt, A, Taylor, DJ (2008) Childhood outcomes after prescription of antibiotics to pregnant women with spontaneous preterm labour: 7-year follow-up of the ORACLE II trial. Lancet 372: pp. 1319-1327 CrossRef
- Hoover, RN, Hyer, M, Pfeiffer, RM, Adam, E, Bond, B, Cheville, AL, Colton, T, Hartge, P, Hatch, EE, Herbst, AL (2011) Adverse health outcomes in women exposed in utero to diethylstilbestrol. N Engl J Med 365: pp. 1304-1314 CrossRef
- Disability and Perinatal care: report of two working groups. NEPU and Oxford HA, Oxford
- Modi, N, Dore, CJ, Saraswatula, A, Richards, M, Bamford, KB, Coello, R, Holmes, A (2009) A case definition for national and international neonatal bloodstream infection surveillance. Arch Dis Child 94: pp. F8-F12
- Standards for hospitals providing neonatal intensive and high dependency care and categories of babies requiring neonatal care. 2nd edition. British Association of Perinatal Medicine; 2001. http://www.bapm.org/publications/documents/guidelines/hosp_standards.pdf
- Classification of health status at 2 years as a perinatal outcome.
- Edwards, IR, Biriell, C (1994) Harmonisation in pharmacovigilance. Drug Saf 10: pp. 93-102 CrossRef
- Honest, H, Forbes, CA, Duree, KH, Norman, G, Duffy, SB, Tsourapas, A, Roberts, TE, Barton, PM, Jowett, SM, Hyde, CJ (2009) Screening to prevent spontaneous preterm birth: systematic reviews of accuracy and effectiveness literature with economic modelling. Health Technol Assess 13: pp. 1-627
- Lachenbruch, PA (2002) Analysis of data with excess zeros. Stat Methods Med Res 11: pp. 297-302 CrossRef
- Farine, D, Mundle, WR, Dodd, J, Basso, M, Delisle, MF, Grabowska, K, Hudon, L, Menticoglou, SM, Murphy-Kaulbeck, LC, Ouellet, A (2008) The use of progesterone for prevention of preterm birth. J Obstet Gynaecol Can 30: pp. 67-77
- ACOG committee opinion no 419.on "The use of progesterone to prevent preterm birth".American College of Obstetricians and Gynecologists. Obstet Gynecol 112: pp. 963-965 CrossRef
- Shennan, A, Jones, G, Hawken, J, Crawshaw, S, Judah, J, Senior, V, Marteau, T, Chinn, S, Poston, L (2005) Fetal fibronectin test predicts delivery before 30 weeks of gestation in high risk women, but increases anxiety. BJOG 112: pp. 293-298 CrossRef
- Sanchez-Ramos, L, Kaunitz, AM, Delke, I (2005) Progestational agents to prevent preterm birth: a meta-analysis of randomized controlled trials. Obstet Gynecol 105: pp. 273-279 CrossRef
- Wolke, D, Meyer, R (1999) Ergebnisse der Bayerischen Entwicklungstudie: implikationen fur theorie und praxis. Kindheit und Entwicklung 8: pp. 24-36 CrossRef
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2393/12/79/prepub
- Trial protocol OPPTIMUM– Does progesterone prophylaxis for the prevention of preterm labour improve outcome?
- Open Access
- Available under Open Access This content is freely available online to anyone, anywhere at any time.
BMC Pregnancy and Childbirth
- Online Date
- August 2012
- Online ISSN
- BioMed Central
- Additional Links
- Author Affiliations
- 1. University of Edinburgh MRC Centre for Reproductive Health, The Queen’s Medical Research Institute, 47 Little France Crescent, Edinburgh, EH16 4TY, UK
- 2. Women’s Health Academic Centre, King’s Health Partners, 10th floor North Wing, St.Thomas’ Hospital, London, SE1 7EH, UK
- 3. Imperial College Faculty of Medicine, Institute for Reproductive and Developmental Biology, Hammersmith Hospital Campus, Du Cane Road, London, W12 0NN, UK
- 4. Peninsula College of Medicine and Dentistry, Peninsula Medical School, Barrack Road, Exeter, EX2 5DW, UK
- 5. Institute of Cellular Medicine, Uterine Cell Signalling Group, 3rd Floor, William Leech Building, The Medical School, Newcastle University, Newcastle, NE2 4HH, UK
- 6. Institute for Women’s Health, University College London, Room 244, Medical School Building, 74 Huntley Street, London, WC1E 6AU, UK
- 7. Centre for Healthcare Randomised Trials (CHaRT), Health Services Research Unit, 3rd Floor Health Sciences Building, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, UK
- 8. University of Warwick Division of Health Sciences, Warwick Medical School, The University of Warwick, Coventry, CV4 7AL, UK
- 9. Histopathology Department, Department of Paediatric Laboratory Medicine, Level 3, Camelia Botnar Laboratories, Great Ormond Street Hospital, London, WC1N 3JH, UK
- 10. School of Nursing, Midwifery and Social Work, The University of Manchester, Manchester, UK
- 11. University of Edinburgh MRC Centre for Reproductive Health, c/o Simpson Centre for Reproductive Health, Royal Infirmary, 51 Little France Crescent, Edinburgh, EH16 4SA, UK